Get Real Time Here
| Open15.910 | Close16.230 |
| Vol / Avg.983.158K / 1.120M | Mkt Cap682.163M |
| Day Range15.350 - 16.555 | 52 Wk Range5.020 - 19.340 |
Cabaletta Bio Stock (NASDAQ:CABA), Quotes and News Summary
Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
| Open15.910 | Close16.230 |
| Vol / Avg.983.158K / 1.120M | Mkt Cap682.163M |
| Day Range15.350 - 16.555 | 52 Wk Range5.020 - 19.340 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.400 | -0.370 | 0.0300 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.370 | 0.0700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-29 | Morgan Stanley | Michael Ulz | Maintains | OverweightOverweight | Lowers | 28.00 | 25.00 |
| 2023-11-29 | HC Wainwright & Co. | Douglas Tsao | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-11-15 | Cantor Fitzgerald | Joshua Schimmer | Maintains | OverweightOverweight | Raises | 40.00 | 50.00 |
| 2023-11-10 | HC Wainwright & Co. | Douglas Tsao | Maintains | BuyBuy | Raises | 17.00 | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CABA | Cabaletta Bio | -0.44% | 682.2M |
| ETNB | 89bio | -0.9% | 745.8M |
| RNA | Avidity Biosciences | -6.71% | 594.6M |
| VALN | Valneva | 5.91% | 830M |
| FDMT | 4D Molecular Therapeutics | 2.47% | 638.7M |
How do I buy Cabaletta Bio (CABA) stock?
You can purchase shares of Cabaletta Bio (NASDAQ: CABA) through any online brokerage.
Who are Cabaletta Bio's (CABA) competitors?
Other companies in Cabaletta Bio’s space includes: 89bio (NASDAQ:ETNB), Avidity Biosciences (NASDAQ:RNA), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Cabaletta Bio (CABA) stock?
The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Morgan Stanley on Wednesday, November 29, 2023. The analyst firm set a price target for 25.00 expecting CABA to rise to within 12 months (a possible 57.04% upside). 24 analyst firms have reported ratings in the last year.
Current Stock Price for Cabaletta Bio (CABA)?
The stock price for Cabaletta Bio (NASDAQ: CABA) is $15.92 last updated December 8, 2023 at 10:06 PM UTC.
Does Cabaletta Bio (CABA) pay a dividend?
There is no dividend information for Cabaletta Bio.
When is Cabaletta Bio (NASDAQ:CABA) reporting earnings?
Cabaletta Bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Cabaletta Bio (CABA) going to split?
There is no upcoming split for Cabaletta Bio.
What sector and industry does Cabaletta Bio (CABA) operate in?
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.